goldman sachs news - Search News

Goldman Sachs Economists See Fed Skipping a Rate Cut

Goldman Sachs Economists See Fed Skipping a Rate Cut in January

The Federal Reserve is likely to signal a slower future pace of easing when it meets later this week and then skip cutting interest rates in January, according to Goldman Sachs Group Inc. economists.

USA TODAY on MSN · 1h

Why the Fed is likely to cut interest rates again despite inflation uptick, solid economy

The Federal Reserve is expected to cut interest rates for a 3rd straight meeting despite a recent inflation pick-up and solid economy and job market.

U.S. News & World Report on MSN · 5h

Fed Likely to Cut Rates This Week Despite Strong Economy

Now, three months later, the economy continues to hold up well and inflation has trended upward in the short term, yet odds are close to 99% that the Fed will lower rates again th

Goldman Sachs, Synthon

Reuters on MSN · 6d

Goldman Sachs sees more larger-scale strategic deals in 2025

Goldman Sachs expects "strategic" deals by companies to accelerate in 2025 including large-scale mergers and acquisitions, its finance chief said on Tuesday.

PE Hub · 3h

BC Partners agrees to sell majority stake in Synthon to Goldman Sachs Alternatives

BC Partners has agreed to sell its majority stake in Synthon to Goldman Sachs Alternatives. Synthon is an international pharmaceutical company, with a platform specialized in developing, manufacturing, and out-licensing complex generic medicines.

The Financial Times · 7h

Goldman Sachs’ investment arm agrees €2bn deal for drugmaker Synthon

Goldman Sachs Asset Management has agreed a more than €2bn deal to acquire drugmaker Synthon from BC Partners, according to people familiar with the matter, as it hopes to capitalise on demand for off-patent versions of complex medicines.

23hon MSN

Goldman Sachs sees limited AI adoption by firms

Artificial adoption by companies remains modest, with only 6.1% of U.S. firms currently utilizing AI to produce goods or ...

NL Times7h

Goldman Sachs set to pay €2 billion for Dutch pharma firm Synthon International

Goldman Sachs’ asset arm is in the process of acquiring the Dutch pharmaceutical company Synthon International for 2 billion ...

24/7 Wall St1d

Investors Are Buying Goldman Sachs Top High-Yield Dividend Picks Hand-Over-Fist

Four top dividend stocks from the Goldman Sachs U.S. Conviction List offer solid total return potential for those seeking ...

2don MSN

Goldman Sachs granted licence for China fund sales

Goldman Sachs received regulatory approval to sell funds in China, the latest U.S. investment bank to get a financial licence ...

2don MSN

Another year of solid spending to boost consumer sector stocks in 2025, Goldman Sachs says

Consumer sentiment and spending will remain strong in 2025, with outsize gains for discretionary stocks, with some ...

Companies that want to go public without a diverse board may still have to get through Goldman Sachs

Goldman Sachs only takes public companies with at least 2 diverse board members. Here's what the Nasdaq ruling means for the ...

Goldman Sachs Names Alzaim Saudi CEO as US Bank Boosts Presence

Goldman Sachs Group Inc. has appointed Omar Alzaim as chief executive officer of its Saudi Arabia operations as it looks to ...

Weirton Daily Times9h

Entrepreneurs complete Goldman Sachs Small Business Program

CHARLESTON — Twenty-six West Virginia small business owners graduated on Friday from the state’s first cohort of Goldman Sachs’ 10,000 Small Businesses program, which aims to boost rural job markets ...

2don MSN

Goldman Sachs to continue to scale tokenization efforts, says Mathew McDermott

Mathew McDermott, Goldman Sachs global head of digital assets, joins CNBC Crypto World's MacKenzie Sigalos to react to ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Goldman Sachs Economists See Fed Skipping a Rate Cut

Goldman Sachs, Synthon

Related topics